|
NOL6 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.195800E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.803600E-01 |
| Normal-vs-Stage2 |
7.540000E-01 |
| Normal-vs-Stage3 |
2.560000E-01 |
| Normal-vs-Stage4 |
9.413600E-02 |
| Stage1-vs-Stage2 |
4.625000E-01 |
| Stage1-vs-Stage3 |
3.108000E-01 |
| Stage1-vs-Stage4 |
1.189360E-01 |
| Stage2-vs-Stage3 |
2.146000E-01 |
| Stage2-vs-Stage4 |
7.620500E-02 |
| Stage3-vs-Stage4 |
3.693800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.303800E-01 |
| Normal-vs-AfricanAmerican |
1.058770E-01 |
| Normal-vs-Asian |
2.104000E-01 |
| Caucasian-vs-AfricanAmerican |
2.071000E-01 |
| Caucasian-vs-Asian |
4.630000E-01 |
| AfricanAmerican-vs-Asian |
5.693000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.065200E-01 |
| Normal-vs-Female |
8.537500E-03 |
| Male-vs-Female |
1.648250E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.886000E-01 |
| Normal-vs-Age(41-60Yrs) |
3.682400E-01 |
| Normal-vs-Age(61-80Yrs) |
3.027400E-01 |
| Normal-vs-Age(81-100Yrs) |
8.742200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.880200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.327000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.887400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.359800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.292200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.243400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
8.055000E-01 |
| Normal-vs-Grade 2 |
3.715000E-01 |
| Normal-vs-Grade 3 |
8.383200E-01 |
| Normal-vs-Grade 4 |
6.833500E-02 |
| Grade 1-vs-Grade 2 |
8.602400E-01 |
| Grade 1-vs-Grade 3 |
8.970400E-01 |
| Grade 1-vs-Grade 4 |
2.049000E-01 |
| Grade 2-vs-Grade 3 |
3.863600E-01 |
| Grade 2-vs-Grade 4 |
1.632160E-01 |
| Grade 3-vs-Grade 4 |
6.887700E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
3.965400E-01 |
| Normal-vs-ccB subtype |
3.013400E-01 |
| ccA subtype-vs-ccB subtype |
7.998400E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.562800E-01 |
| Normal-vs-N1 |
5.316900E-03 |
| N0-vs-N1 |
5.018500E-02 |
|
|
